New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Beyond Identity Joins ForgeRock’s Trust Network of Certified Technology Partners to Deliver Passwordless Single Sign-On and Risk-Based Authorization
-
Beyond Identity Joins ForgeRock’s Trust Network of Certified Technology Partners to Deliver Passwordless Single Sign-On and Risk-Based Authorization
-
Firms will invest more in AI after the pandemic, but delivering ROI will take skill, scale, and time
-
DataRobot Introduces Major Enhancements to Its Enterprise AI Platform
-
Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics
-
Topia Partners with BCD Travel to Automate Business Travel and Distributed Workforce Compliance
-
DataRobot Introduces More Intelligent Tomorrow Podcast
-
Xfund 3 Raises Oversubscribed Fund to Back University-Based Innovation
-
CIT’s Virginia Founders Fund Invests in Techulon to Advance the Development of Targeted Antibiotics
-
Topia Achieves Record Growth Driven By its Tax Compliance Solutions for Newly Distributed Workforces
-
Lumos Pharma to Participate in Upcoming Investor Conferences
-
Lumos Pharma to Participate in Upcoming Investor Conferences
-
CIT Announces MACH37 Investment in Cervais for Improved Endpoint Security
-
GRID Raises $12M in Series A Funding led by NEA to Revolutionize Data Work
-
Aetion adds strategic investment from Johnson & Johnson Innovation - JJDC, Inc., EDBI, Greenspring Associates to expand RWE offerings
-
Form SC 13D Bloom Energy Corp Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Total Economic Impact Study Reveals 514% Return on Investment with DataRobot
-
Form 4 Bloom Energy Corp For: Aug 14 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
DataRobot Appoints Parm Uppal as Chief Revenue Officer
-
Timescale Brings Powerful Time-Series Data Analysis to Developers Worldwide, Now Available in 75+ Cloud Regions
-
DataRobot Launches Pathfinder: A Comprehensive Library of 100+ AI Use Cases
-
Form 4 Cloudflare, Inc. For: Aug 07 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
AVEO Oncology Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Verona Pharma plc: TR-1: Standard form for notification of major holdings
-
OmniSci Shortlisted for 2020 SaaS Awards
-
Topia Announces Topia Compass, Delivering Business Travel and Distributed Workforce Compliance Management
-
Pancreatic Cancer Action Network Appoints New Leadership And Members To Its Board Of Directors
-
New Survey on Pandemic’s Effects Reveals Mixed State of Mind for Essential Workers, Boomers and Millennials
-
New Survey on Pandemic’s Effects Reveals Mixed State of Mind for Essential Workers, Boomers and Millennials
-
USIJ Releases Report on The Importance of an Effective and Reliable Patent System to Critical Technologies
-
Form SC 13D/A GENOCEA BIOSCIENCES, Filed by: New Enterprise Associates 16, L.P.
-
Entel Chooses OmniSci to Improve Customer Satisfaction By Extending Best-in-Class Mobile Operations
-
The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis
-
Eargo Announces $71 Million Series E Financing
-
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
-
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
-
Humana and Strive Health Announce Kidney Disease Care Coordination Services Collaboration In Kentucky and Indiana
-
Lumos Pharma, Inc. (LUMO) Sells Priority Review Voucher (PRV) to Merck at $100M Valuation
-
Lumos Pharma Announces Sale of Priority Review Voucher
-
Lumos Pharma Announces Sale of Priority Review Voucher
-
MBX Biosciences Closes $34.6 Million Series A Financing in Rare Endocrine Diseases
-
Form 3 Inozyme Pharma, Inc. For: Jul 23 Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D Nkarta, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Raise Marketplace LLC Launches Slide Mobile Payments App for Consumers to Earn Unlimited 4% Cash Back at Retail Locations Nationwide
-
Beyond Identity Joins Ping Identity’s Technology Alliance Program to Enable Passwordless Single Sign-On
-
DataRobot Extends Pro Bono AI Platform Licenses to Nonprofit and Social Good Organizations
-
Beyond Identity Joins Ping Identity’s Technology Alliance Program to Enable Passwordless Single Sign-On
-
Form SC 13D Inventiva S.A. Filed by: New Enterprise Associates 17, L.P.

